Zurich, Switzerland

Charles Weissmann


Average Co-Inventor Count = 1.0

ph-index = 2

Forward Citations = 106(Granted Patents)


Company Filing History:


Years Active: 1985-2004

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Charles Weissmann

Introduction

Charles Weissmann is a prominent inventor based in Zurich, Switzerland. He is known for his significant contributions to the field of molecular biology, particularly in the development of recombinant DNA technology. With a total of 2 patents, Weissmann has made remarkable advancements that have implications in medical science.

Latest Patents

Weissmann's latest patents focus on DNA sequences and recombinant DNA molecules that are crucial for producing human interferon-like polypeptides. These inventions include methods for creating DNA sequences that code for polypeptides exhibiting biological or immunological activity similar to human interferon. The recombinant DNA molecules he developed allow for the production and identification of genes and polypeptides that can be utilized in antiviral and antitumor therapies. His work has paved the way for innovative treatments in the fight against various diseases.

Career Highlights

Throughout his career, Weissmann has worked with notable companies such as Biogen, N.V. and Biogen, Incorporated. His experience in these organizations has contributed to his expertise in biotechnology and molecular genetics. His research has not only advanced scientific understanding but has also led to practical applications in medicine.

Collaborations

Due to space constraints, the collaborations section will be omitted.

Conclusion

Charles Weissmann's contributions to the field of molecular biology through his patents and career achievements highlight his role as a key innovator in biotechnology. His work continues to influence the development of therapeutic agents that can combat serious health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…